We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600648:SSEShanghai Waigaoqiao Free Trade Zone Group Co., Ltd. Class A Analysis

Data as of 2026-06-14 - not real-time

CN¥8.88

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Shanghai Waigaoqiao Free Trade Zone is trading just above a clear technical support level while the 20‑day moving average sits below both the 50‑day and 200‑day averages, confirming a bearish price trajectory. The Relative Strength Index is deep in oversold territory, suggesting a possible short‑term bounce, and the MACD remains in a bearish configuration. Volume has been on the rise, indicating renewed market participation despite the downtrend. Valuation metrics are compelling, with the price‑to‑earnings multiple markedly below the industry average and a price‑to‑book ratio under one, positioning the stock as a relative value play. A dividend yield exceeding four percent and a payout ratio near fifty percent provide an attractive income component.
However, the balance sheet is heavily leveraged, with debt far outweighing cash and a debt‑to‑equity ratio that signals considerable financial risk. Free cash flow is negative, limiting the company’s ability to fund growth or reduce leverage without external capital. Profitability is modest, with return on equity and operating margins only in the low single digits. The business operates in a regulated industrial sector within China, exposing it to policy and geographic risks, while its low beta suggests limited sensitivity to broader market swings. Given the mix of cheap valuation, strong dividend, and significant leverage, investors should weigh the upside potential against the financial vulnerabilities.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical trend with price near support
  • Oversold RSI indicating possible short‑term rebound
  • Rising volume supporting price stability

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount to industry peers
  • Attractive dividend yield
  • Potential for earnings stabilization if leverage is managed

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt load and negative free cash flow limiting growth
  • Sustained dividend income offsetting earnings volatility
  • Regulatory environment in China may impact core operations

Key Metrics & Analysis

Financial Health

Revenue Growth-0.50%
Profit Margin15.25%
P/E Ratio12.5
ROE6.15%
ROA0.90%
Debt/Equity140.96
P/B Ratio0.8
Op. Cash FlowCN¥434.6M
Free Cash FlowCN¥-2627711232
Industry P/E30.6

Technical Analysis

TrendBearish
RSI26.1
SupportCN¥8.63
ResistanceCN¥10.01
MA 20CN¥9.47
MA 50CN¥10.00
MA 200CN¥10.57
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

GradeUndervalued
TypeValue
Dividend Yield4.01%

Risk Assessment

Beta0.25
Volatility23.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.